By: Jen Christensen
(CNN) — The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer's disease.
Writer for https://t.co/lS4gy6ZgtC & Producer for CNN (Health, Climate, Social Justice, & Investigative). National VP of Broadcast NLGJA.🏳️🌈 she/her, Bennington, Butler grad
International
Jen Christensen's coverage predominantly focuses on health and safety, with a significant emphasis on government announcements and data citations. She would likely be interested in pitches related to healthcare policies, public health initiatives, scientific research breakthroughs or warnings about potential health risks.
Given her extensive use of cited data and government announcements, she may find value in stories backed by robust statistics or those that analyze governmental decisions impacting public health. Pitches that offer expert insights into emerging trends in healthcare, pharmaceuticals, or provide analysis of relevant scientific studies could also capture her interest.
Her broad topics covered include Health and Safety, Counterfeit Products FDA regulations as well as shopping-related issues such as the gift card scam explained and how to avoid it.
This information evolves through artificial intelligence and human feedback. Improve this profile .